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Thesis Summary 
  The purpose of this study is to solve the existing problems for vascular interventional radiology (IVR) 
treatment, which has been developed as minimally invasive therapy, from the approach on polymer 
material and to evaluate the effectiveness of the developments. 
  Chapter 1 describes the background, medical devices, and problems of the vascular IVR. Especially, 
medical devices such as stents for narrowing of blood vessel, covered stents for aneurysm, and embolic 
materials for liver cancer were studied in this thesis. 
In chapter 2 and chapter 3, the combination of poly (MPC-co-BMA) (MPC polymer), which is a 
copolymer of 2-methacryloyloxyethyl phosphorylcholine (MPC) and butyl methacrylate (BMA), and the 
micro-patterned hydrogenated amorphous carbon (a-C:H) (micro-patterned a-C:H/MPC polymer) were 
fabricated. Then the functionality as a stent coating, endothelialization property, and blood compatibility 
were evaluated. 
  In chapter 2, small-patterned a-C:H/MPC polymer and large-patterned a-C:H/MPC polymer were 
fabricated. The distances between the blocks constituting each sample were the same and the areas 
were different from each other. In the vascular endothelial cell culture test, in the small-patterned 
sample, it was observed that one a-C:H block was covered with one cell, whereas in the large-patterned 
sample the cell was not influenced by the shape of the a-C:H blocks. As the result, it was shown that the 
vascular endothelial cells were affected by controlling the area of an a-C:H block.  
  In chapter 3, by adding basic fibroblast growth factor (bFGF) to the MPC polymer layer of 
micro-patterned a-C:H / MPC polymer, bFGF release property were added. In the vascular endothelial 
cell proliferation evaluation test, on the bFGF-containing sample, vascular endothelial cells occupied 
about 60% of the area ratio after 24 hours of culture. On the other hand, on the sample without bFGF, it 
took about 40 hours after the culture. Thus, it was shown that bFGF contained in the sample promoted 
vascular endothelial cell proliferation. 
  In chapter 4, the sample of the stent cover (micro-patterned a-C:H/MPC polymer) (non-woven fabric) 
was made by the electrospinning method. As a result of evaluating the drug release test, it was found 
that the drug release property could be controlled by changing the coverage area ratio of the a-C:H film. 
  In chapter 5, a composite gel of Lipiodol (LPD), a lipid-soluble X-ray contrast agent, and 
polycaprolactone (PCL), a biodegradable polymer, were processed to microbeads by using the 
microfluidic device designed as the embolic material for the treatment of the hepatic cancer. The beads 
for hepatic arterial embolization need to have radiopaque and degradation property. As a result of X-ray 
visibility and biodegradability in vitro evaluation, the CT value was over 1500 HU, which is necessary for 
X-ray contrast. Furthermore, from the in vivo evaluation of biodegradability, the embolized rabbit hepatic 
artery was reopened within one month. This shows the fabricated microbeads had the controllability of 
degradation property. 
  Chapter 6 summarizes the results obtained in each chapter, and concludes this paper. 
 
